← Evidence map

ReviewMedical gas research2025

Evaluation of the potential efficacy of the nitric oxide donor molsidomine for the treatment of schizophrenia.

Nikolaos PitsikasPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39511754